Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease

Beryllium (Be)-antigen presentation to Be-specific CD4(+) T cells from the lungs of patients with chronic beryllium disease (CBD) results in T cell proliferation and TNF-alpha secretion. We tested the hypothesis that Be-induced, CBD bronchoalveolar lavage (BAL) T cell, transcription-dependent, TNF-a...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory cell and molecular biology Vol. 36; no. 2; pp. 191 - 200
Main Authors Sawyer, Richard T, Fontenot, Andrew P, Barnes, Tristan A, Parsons, Charles E, Tooker, Brian C, Maier, Lisa A, Gillespie, May M, Gottschall, E Brigitte, Silveira, Lori, Hagman, James, Newman, Lee S
Format Journal Article
LanguageEnglish
Published United States American Thoracic Society 01.02.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Beryllium (Be)-antigen presentation to Be-specific CD4(+) T cells from the lungs of patients with chronic beryllium disease (CBD) results in T cell proliferation and TNF-alpha secretion. We tested the hypothesis that Be-induced, CBD bronchoalveolar lavage (BAL) T cell, transcription-dependent, TNF-alpha secretion was accompanied by specific transcription factor upregulation. After 6 h of Be stimulation, CBD BAL cells produced a median of 883 pg/ml TNF-alpha (range, 608-1,275 pg/ml) versus 198 pg/ml (range, 116-245 pg/ml) by unstimulated cells. After 12 h CBD BAL cells produced a median of 2,963 pg/ml (range, 99-9,424 pg/ml) TNF-alpha versus 55 pg/ml (range, 0-454) by unstimulated cells. Using real-time RT-PCR, Be-stimulated TNF-alpha production at 6 h was preceded by a 5-fold increase in TNF-alpha pre-mRNA copy number:beta-actin copy number (Be median ratio 0.21; unstimulated median ratio 0.04). The median ratio of mature TNF-alpha mRNA:beta-actin mRNA was upregulated 1.4-fold (Be median ratio 0.17; unstimulated median ratio 0.12). Be exposure in the presence of the transcription inhibitor pentoxifylline (PTX) decreased CBD BAL cell TNF-alpha pre-mRNA levels > 60%, whereas treatment with the mRNA splicing inhibitor 2-aminopurine (2AP) decreased levels 40% relative to Be exposure alone. PTX treatment decreased mature TNF-alpha mRNA levels 50% while 2AP decreased levels > 80%, relative to Be exposure alone. Beryllium exposure specifically upregulated transcription factors AP-1 and NF-kappaB. The data suggest that Be exposure induces transcription-dependent TNF-alpha production, potentially due to upregulation of specific transcription factors.
Bibliography:This study was supported by RO1 ES06538, PO1 ES11810, RO1 HL62410, K08 HL03887, and MO1 RR00051 from the National Institutes of Health.
Conflict of Interest Statement: None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.
Originally Published in Press as DOI: 10.1164/rccm.2006-0021TR on September 15, 2006
Correspondence and requests for reprints should be addressed to Dr. R. T. Sawyer, Division of Allergy, Immunology and Transplantation, NIAID, DHHS, 6610 Rockledge Drive, Room 3103, Bethesda, MD. E-mail: sawyerr@niaid.nih.gov
ISSN:1044-1549
1535-4989
DOI:10.1165/rcmb.2006-0021TR